AMERICAN ASSOCIATION FOR CANCER RESEARCH

Lobbying for AMERICAN ASSOCIATION FOR CANCER RESEARCH

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $100,000.00 expenses · posted Apr 17, 2026

Lobbying activity 4

Medical/Disease Research/Clinical Labs

Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention

Tobacco

Tobacco control and prevention Tobacco cessation

Budget/Appropriations

FY 2027 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.

Health Issues

Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.